🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of VAN00010 study is to assess the safety and immunogenicity of...
Status
Completed
Location
Accel Research Site - Birmingham Clinical Research Unit- Site Number : 8400080
Start Date
2023-10-31
Trial ID
NCT06128733
The primary objective of this study is to demonstrate the non-inferiority o...
Status
Completed
Location
Alabama Clinical Therapeutics Site Number : 8400036
Start Date
2018-10-04
Trial ID
NCT03691610
Treatments Being Tested
The primary objective of this study was to describe the safety profile of M...
Status
Completed
Location
Birmingham Pediatric Associates-Site Number:8400049
Start Date
2018-09-17
Trial ID
NCT03673462
Treatments Being Tested
This study will evaluate the safety and immune response of the Novartis Men...
Status
Completed
Location
Growing Up Pediatrics
Start Date
2007-03
Trial ID
NCT00474526
The Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection...
Status
Active Not Recruiting
Location
Botswana Harvard Health Partnership
Start Date
2024-10-14
Trial ID
NCT06436274
Treatments Being Tested
This study aims to evaluate the immunogenicity, safety and tolerability of ...
Status
Unknown
Location
St Georges University Hospital
Start Date
2019-02-21
Trial ID
NCT03682939
Treatments Being Tested
This study evaluated the immunogenicity and safety of a single dose of MenQ...
Status
Completed
Location
Investigational Site Number : 0320002
Start Date
2023-09-07
Trial ID
NCT05929651
Treatments Being Tested
MENPI is an investigator-initiated single-centre randomized controlled tria...
Status
Recruiting
Location
Hvidovre Hospital
Start Date
2021-04-28
Trial ID
NCT04875819